Evidence map›Paper›PMID 35804969›Full record

ReviewCancers2022

Magnetic Resonance Spectroscopy in Diagnosis and Follow-Up of Gliomas: State-of-the-Art.

Malik Galijasevic, Ruth Steiger, Stephanie Mangesius, Julian Mangesius, Johannes Kerschbaumer, Christian Franz Freyschlag, Nadja Gruber, Tanja Janjic, Elke Ruth Gizewski, Astrid Ellen Grams

Abstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Accelerating discovery: Transformative clinical trial models in neuro-oncology.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Ultra-low fieldCommunications chemistry · 2026
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Preclinical and Clinical Use of Indigenously DevelopedACS pharmacology & translational science · 2023
    Review
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Malik GalijasevicDepartment of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-6577-0784
Ruth SteigerDepartment of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-6905-9575
Stephanie MangesiusDepartment of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-5790-2724
Julian MangesiusDepartment of Radiation Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-0855-1870
Johannes KerschbaumerDepartment of Neurosurgery, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-9997-4336
Christian Franz FreyschlagDepartment of Neurosurgery, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-8228-8217
Nadja GruberVASCage-Research Centre on Vascular Ageing and Stroke, 6020 Innsbruck, Austria.ORCID 0000-0001-5158-020X
Tanja JanjicDepartment of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-3524-8332
Elke Ruth GizewskiDepartment of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-6859-8377
Astrid Ellen GramsDepartment of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-2304-3946

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preoperative grade prediction is important in diagnostics of glioma. Even more important can be follow-up after chemotherapy and radiotherapy of high grade gliomas. In this review we provide an overview of MR-spectroscopy (MRS), technical aspects, and different clinical scenarios in the diagnostics and follow-up of gliomas in pediatric and adult populations. Furthermore, we provide a recap of the current research utility and possible future strategies regarding proton- and phosphorous-MRS in glioma research.

Indexed as

gliomaimaging biomarkersmagnetic resonance spectroscopy

Identifiers

PMID35804969
PMCPMC9264890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.